Medical research

New molecule to fight against transthyretin amyloidosis

Researchers from IBB-UAB have developed a second-generation molecule that significantly improves the stabilization and inhibition of the aggregation of proteins involved in Transthyretin Amyloidosis (ATTR), a group of minority ...

Oncology & Cancer

Canceling cancer with T cells

What if we could engineer our immune system to make the human body better at fighting cancer? Professor Roy Mariuzza is part of a major research effort aimed at doing just that. An expert in the structural biology of immune ...

page 4 from 40